Author:
Damase Tulsi Ram,Sukhovershin Roman,Zhang Min,Kiss Daniel L.,Cooke John P.
Publisher
Springer International Publishing
Reference96 articles.
1. Aldrich C, Leroux-Roels I, Huang KB et al (2021) Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: a phase 1 trial. Vaccine 39:1310–1318
2. Alexopoulou L, Holt AC, Medzhitov R et al (2001) Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413:732–738
3. Arcturus Therapeutics, Inc. (2020) A phase 1 randomized, double blinded, placebo controlled, ascending dose study to assess the safety, tolerability, and pharmacokinetics of single doses of ARCT-810 in healthy adult subjects. clinicaltrials.gov
4. Arcturus Therapeutics, Inc. (2021) A phase 1b randomized, double blinded, placebo controlled, ascending dose study to assess the safety, tolerability, and pharmacokinetics of single doses of ARCT-810 in clinically stable patients with ornithine transcarbamylase deficiency. clinicaltrials.gov
5. Baden LR, El Sahly HM, Essink B et al (2021) Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 384:403–416
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献